Oxybutynin/Clonidine

奥昔布宁/可乐定

Report date: 2022/07/04 19:38:02

Base Information

Drug NameOxybutynin/Clonidine
Drug Alias NameOxybutynin/Clonidine奥昔布宁/可乐定可乐定和奥昔布宁Clonidine•OxybutyninClonidine-Oxybutynin +[12] 
ClassificationSmall molecules
Mechanisms of ActionImidazoline receptor agonistsMuscarinic acetylcholine receptor antagonists
TargetsImidazoline receptorMuscarinic acetylcholine receptor
Therapy Area/IndicationsSialorrhea
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsYes OxybutyninClonidine
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSummit Pharmaceuticals International
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOrient Pharma Co Ltd
Active IndicationsN/A
Inactive IndicationsSialorrhea

Other Information

ATC CodeN/A
Related LinksN/A